Results 91 to 100 of about 278,227 (245)

Long‐term test and retest reliability of clinical vergence testing

Ophthalmic and Physiological Optics, Volume 45, Issue 7, Page 1630-1641, November 2025.
Abstract Purpose To establish long‐term reliability measures for vergence testing in a control population of adolescents. Methods Healthy participants between 12 and 17.5 years with normal binocular vision were recruited from 10 clinical sites. Cover test, near point of convergence (NPC), positive and negative fusional vergences, vergence facility (12∆
Mitchell Scheiman, Aparna Raghuram, Christina Master, Matthew L. Robich, Andrew Toole, Erica R. Shelton, Gayathri Srinivasan, Sophia Marusic, Siva Meiyeppen, Lisa A. Jordan, Tawna L. Roberts, EPICC Study Group, Tawna L. Roberts, Lisa A Jordan, Kristine N. Dalton, Gerald A. Grant, Yaping Joyce Liao, Jason Porter, Laura K. Purcell, Mitchell Scheiman, Mark A. Swanson, Suresh Viswanathan, Lisa A Jordan, Loraine T. Sinnott, Matthew L. Robich, Kimberly J. Shaw, Jill A. Myers, Stacey S. Choi, Jason Porter, Nimesh Patel, Chris Koutures, Jennifer Platt, Aparna Raghuram, Michael O’Brien, Neerali Vyas, Emily Wiecek, Sophia Marusic, Debora Ghosh, Carissa Wu, Christina Master, Lindsey Calandra, Katherine Easby, Anne Mozel, Olivia Podolak, Kathryn Rownd, Melissa Godfrey, Ian McGinnis, Colleen Ford, Kelsy Stenger, Karlie Pollock, Kaitlyn Housel, Angela Chen, Silvia Han, Kristine Huang, Susan M. Parker, Jillian Youngerman, Surbhi Bansal, Natalie Breau, Judith Wu, Allegra Burgher, Cristina Llerena Law, Alessandra Posey, Amar Sayani, Lailah Issac, Ryan Bennett, Katherine Green, Ahmed Riaz, Mitchell Scheiman, Siva Meiyeppen, Tawna Roberts, Gerald Grant, Emily Kraus, Shannon Beres, Heather Moss, Anna Wan, Kristin Slinger, Joellen Leonen, Amber Hu, Gayathri Srinivasan, Christabel Baah, Erin Moix Grieb, Caitlyn Lew, Tyler Vandiver, Kylie Clewes, Surbhi Bansal, Angela Lumba‐Brown, Arvind Balaji, Suresh Viswanathan, Patricia A. Modica, Ashwin Badrinath Pothiadia‐Irungovel, Matthew Vaughn, Catherine McDaniel, Ann Morrison, Douglas Widmer, Michelle Buckland, Erica Shelton, Andrew J. Toole, Nancy Stevens, Mark W. Swanson, Sara Gould, Jenifer Montejo, Laura Ferrill, Erin Swanson‐Kimani, Katherine K. Weise, Zenia Cardona, Kristine N. Dalton, Laura K. Purcell, Tammy Labreche, Julie Shalhoub, Dania Abuleil   +109 more
wiley   +1 more source

Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy

Thyroid Research, 2019
Background Treatment of moderate to severe Graves’ orbitopathy (GO) is based mainly on intravenous pulses of methylprednisolone. High doses of methylprednisolone can exert several adverse effects, some of which might be life-threatening. The objective of
Dorota Walasik-Szemplińska, Grzegorz Kamiński, Iwona Sudoł-Szopińska   +2 more
doaj   +1 more source

Unexpected conversion from hypothyroidism to an euthyroid state due to Graves’ disease in a patient with an ectopic thyroid [PDF]

, 2013
A 15-year-old woman was diagnosed with hypothyroidism and unilateral ectopic thyroid. Levothyroxine treatment was introduced; however, the patient was non-compliant and took the medication irregularly.
Aleksandra Hernik, Ewelina Szczepanek-Parulska, Marek Ruchala   +2 more
core   +1 more source

Sirolimus as a second-line treatment for Graves’ orbitopathy

Journal of Endocrinological Investigation, 2022
A beneficial effect of sirolimus in Graves’ orbitopathy (GO) was reported, suggesting a possible use in clinical practice. We conducted an observational, single-centre, no-profit, clinical study to investigate the efficacy of sirolimus as a second-line ...
G. Lanzolla, M. N. Maglionico, Simone Comi, F. Menconi, P. Piaggi, C. Posarelli, M. Figus, C. Marcocci, M. Marinò   +8 more
semanticscholar   +1 more source

Ten Year Outcome of Anti‐Thyroid Drug Treatment for First Episode Graves' Thyrotoxicosis: The Predictive Importance of TRAb

Clinical Endocrinology, Volume 103, Issue 4, Page 612-618, October 2025.
ABSTRACT Objective To establish the risk and time course of recurrent thyrotoxicosis following withdrawal of anti‐thyroid drugs (ATD) and risk factors for recurrence. Design Single‐centre retrospective study. Methods Two hundred and ninety people with a first episode of Graves' thyrotoxicosis, who completed a course of ATD, were included.
Nyo Nyo Z. Tun, Nicola N. Zammitt, Mark W. J. Strachan, Jonathan R. Seckl, Fraser W. Gibb   +4 more
wiley   +1 more source

Thyroid associated orbitopathy

Indian Journal of Ophthalmology, 2012
Thyroid associated orbitopathy, also known as Graves′ orbitopathy, is typically a self-limiting autoimmune process associated with dysthyroid states.
Rajat Maheshwari, Ezekiel Weis
doaj   +1 more source

Increased percentage of L-selectin+ and ICAM-1+ peripheral blood CD4+/CD8+ T cells in active Graves' ophthalmopathy. [PDF]

, 2009
The purpose of the study was to evaluate the percentage of CD4+/CD8+ peripheral T cells expressing CD62L+ and CD54+ in patients with Graves' disease and to assess if these estimations could be helpful as markers of active ophthalmopathy.
A Bossowski, A De Bellis, A Heufelder, A Kretowski, A Modelska-Ziolkiewicz, A Pappa, A Pappa, Alina Bakunowicz-Lazarczyk, Anna Stasiak-Barmuta, G Foerster, G Kulig, G Liu, I Wakelkamp, I Wakelkamp, J Aniszewski, J Mysliwiec, Janusz Mysliwiec, L Bartalena, M Kazim, Maria Gorska, N Xia, P Boulos, Przemysław Pawlowski, R Bahn, S Yan, W Wiersinga   +25 more
core   +3 more sources

Patterns of Teprotumumab‐Induced Hearing Dysfunction: A Systematic Review

Otolaryngology–Head and Neck Surgery, Volume 173, Issue 3, Page 539-545, September 2025.
Abstract Objective Hearing loss has been reported after administration of the monoclonal antibody teprotumumab. The purpose of this study was to review available evidence regarding the patterns of teprotumumab‐related ototoxicity. Data Sources PubMed, EMBASE, and Cochrane Library.
Kevin Wong, Priya Arya, Yansy Salmeron, Douglas C. Bigelow, Michael J. Ruckenstein, Shubhasree Banerjee, Madhura Tamhankar, Jason A. Brant, Tiffany P. Hwa   +8 more
wiley   +1 more source

Extra-ocular muscle MRI in genetically-defined mitochondrial disease [PDF]

, 2015
Conventional and quantitative MRI was performed in patients with chronic progressive external ophthalmoplegia (CPEO), a common manifestation of mitochondrial disease, to characterise MRI findings in the extra-ocular muscles (EOMs) and investigate whether
Cathy Woodward, Christopher D. J. Sinclair, Fion Bremner, Gordon T. Plant, Indran Davagnanam, Jasper M. Morrow, John S. Thornton, Mary G. Sweeney, Michael G. Hanna, Nadeem Ali, Robert D. S. Pitceathly, Shamima Rahman, Tarek A. Yousry   +12 more
core   +1 more source

British Thyroid Association Survey of Graves' Disease Management in the UK

Clinical Endocrinology, Volume 103, Issue 3, Page 376-384, September 2025.
ABSTRACT Background Recent years have seen changes and uncertainties in evidence and guideline recommendations in Graves' disease treatment. To understand the impact of these developments on current practice, we undertook a survey of Graves' disease management in the United Kingdom and compared this to other national and international surveys.
Michael Atkinson, Medha Agrawal, Koteshwara Muralidhara, Prakash Abraham, Bijay Vaidya, Onyebuchi E. Okosieme   +5 more
wiley   +1 more source